The list of our invited speakers is now sealed. As usual, we will host world leaders from the industry and academia from all continents, covering all aspects of peptides to drugs (hormones, antimicrobials, immunomodulators and toxins), from discovery to market.

Opening lecture
	Richard DIMARCHI	Indiana University, USA	The pursuit of transformational medicines
Plenary lectures
	Daniel BERTRAND	HiQScreen, Switzerland	The importance of small peptides in ion channels drug discovery
	Andrew BUTLER	The Scripps Research Institute, USA	Assessment of a potential peptide-based drug candidate (adropin) for treating obesity-related metabolic disorders
	Angelika FRETZEN	Ironwood Pharmaceuticals, USA	Development of Linaclotide as a A Guanylate Cyclase C agonist for the treatment of irritable bowel syndrome with constipation and chronic constipation
	Glenn KING	University of Queensland, Australia	Development of a high-throughput pipeline for venoms-based drug discovery
	Michel LAZDUNSKI	CNRS & Theralpha SAS, France	Venom peptides against pain
	Michael PENNINGTON	Peptides International, USA & Toxinomics Foundation, Switzerland	Advancing ShK peptide into the clinic for treatment of Multiple Sclerosis
	Claudio SCHTEINGART	Ferring Research Institute Inc., USA	Oxytocin and vasopressin: a bounty of drugs from two natural peptides
	Ronald SWANSON	Janssen Research & Development, USA	Venom Peptide Engineering: Increasing Throughput for Drug Discovery
	James TAM	Nanyang Technological University, Singapore	Engineering of Proteinaceous Orally Active Bradykinin Peptide Antagonists for Inflammatory Pain
	Matthias TSCHÖP	Helmholz Centre & Technical University, Germany	Toward a cure for diabesity: From gastrointestinal hormones to combinatorial drugs
Closing lecture
	Thomas VORHERR	Novartis Pharma, Switzerland	Discovery of peptide therapeutics
Peptides & Elephants sponsored oral presentation
	Carsten GRÖTZINGER	Charité - Universitätsmedizin Berlin, Germany	Short chemerin analogues for tumor targeting